Nov 23 (Reuters) - Medincell SA MEDCL.PA , EIB:
* FRANCE : EIB AND MEDINCELL SIGN A NEW €40 MILLION LOAN
AGREEMENT
TO SUPPORT DEVELOPMENT OF INNOVATIVE TREATMENTS
* 40 MILLION EUROS LOAN IS INTENDED FOR DEVELOPMENT OF
TREATMENTS
BASED ON MEDINCELL'S PROPRIETARY LONG-ACTING INJECTABLE
TECHNOLOGY AIMING AT SIGNIFICANTLY ENHANCE PATIENT CARE AND
QUALITY OF LIFE
* THIS EIB INVESTMENT IS GUARANTEED BY EUROPEAN FUND FOR
STRATEGIC
INVESTMENTS, CENTRAL PILLAR OF INVESTMENT PLAN FOR EUROPE
* FIRST PRODUCT USING MEDINCELL'S BEPO® TECHNOLOGY IS
EXPECTED TO
REACH U.S. MARKET IN FIRST HALF OF 2023
Source text for Eikon: ID:nBw7qWZfBa
Further company coverage: MEDCL.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))